About Nanovista
Nanovista is a company based in Toronto (Canada) founded in 2015.. Nanovista has raised $2.3 million across 1 funding round from investors including GreenSky Ventures. Nanovista offers products and services including Multimodal Imaging Agent. Nanovista operates in a competitive market with competitors including ARTMS, NorthStar Medical Radioisotopes, Niowave, Ground Fluor Pharmaceuticals and AZI, among others.
- Headquarter Toronto, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Nanovista Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.3 M (USD)
in 1 rounds
-
Latest Funding Round
$2.3 M (USD), Seed
Feb 12, 2018
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanovista
Nanovista offers a comprehensive portfolio of products and services, including Multimodal Imaging Agent. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Agent for real-time tumor visualization in cancer surgery.
Funding Insights of Nanovista
Nanovista has successfully raised a total of $2.3M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.3 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.3M
-
First Round
First Round
(12 Feb 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2018 | Amount | Seed - Nanovista | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanovista
Nanovista has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include GreenSky Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage Canadian B2B startups are funded by GreenSky Ventures.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanovista
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanovista
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanovista Comparisons
Competitors of Nanovista
Nanovista operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ARTMS, NorthStar Medical Radioisotopes, Niowave, Ground Fluor Pharmaceuticals and AZI, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Radioisotope technologies and services are developed and provided by ARTMS.
|
|
| domain | founded_year | HQ Location |
Provider of sourcing, purification, and separation technologies for the Nuclear Medicine market
|
|
| domain | founded_year | HQ Location |
Devices and radioisotopes for nuclear imaging are provided by Niowave.
|
|
| domain | founded_year | HQ Location |
Proprietary chemistry for pharmaceutical synthesis is developed by the company.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for diagnostic imaging are developed and produced.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Nanovista
When was Nanovista founded?
Nanovista was founded in 2015 and raised its 1st funding round 3 years after it was founded.
Where is Nanovista located?
Nanovista is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Is Nanovista a funded company?
Nanovista is a funded company, having raised a total of $2.3M across 1 funding round to date. The company's 1st funding round was a Seed of $2.3M, raised on Feb 12, 2018.
What does Nanovista do?
Nanovista was founded in 2015 in Toronto, Canada, with operations centered on the medical technology sector. Focus is placed on creating visualization agents to support image-guided procedures, including surgery, radiotherapy, and drug delivery. Development efforts include CF800, an agent for image-guided surgery currently in Phase 12 clinical trials. Activities are conducted to improve intervention accuracy and outcomes in healthcare settings.
Who are the top competitors of Nanovista?
Nanovista's top competitors include ARTMS, NorthStar Medical Radioisotopes and Niowave.
What products or services does Nanovista offer?
Nanovista offers Multimodal Imaging Agent.
Who are Nanovista's investors?
Nanovista has 1 investor. Key investors include GreenSky Ventures.